Mathew SJ - Search Results

1

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.

Jha MK, Mathew SJ. Jha MK, et al. Among authors: mathew sj. Am J Psychiatry. 2023 Mar 1;180(3):190-199. doi: 10.1176/appi.ajp.20230025. Am J Psychiatry. 2023. PMID: 36855876 Review.

2

Glycine transporter-I inhibitors: a new class of antidepressant?

Mathew SJ. Mathew SJ. Biol Psychiatry. 2013 Nov 15;74(10):710-1. doi: 10.1016/j.biopsych.2013.08.019. Biol Psychiatry. 2013. PMID: 24144323 No abstract available.

3

Deep Brain Stimulation for Depression Informed by Intracranial Recordings.

Sheth SA, Bijanki KR, Metzger B, Allawala A, Pirtle V, Adkinson JA, Myers J, Mathura RK, Oswalt D, Tsolaki E, Xiao J, Noecker A, Strutt AM, Cohn JF, McIntyre CC, Mathew SJ, Borton D, Goodman W, Pouratian N. Sheth SA, et al. Among authors: mathew sj. Biol Psychiatry. 2022 Aug 1;92(3):246-251. doi: 10.1016/j.biopsych.2021.11.007. Epub 2021 Nov 22. Biol Psychiatry. 2022. PMID: 35063186 Free PMC article. Clinical Trial.

4

Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine Study.

Feeney A, Hoeppner BB, Freeman MP, Flynn M, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, DeBattista C, Ionescu DF, Cusin C, Papakostas GI, Jha MK, Fava M. Feeney A, et al. Among authors: mathew sj. J Clin Psychiatry. 2022 Nov 14;84(1):22m14491. doi: 10.4088/JCP.22m14491. J Clin Psychiatry. 2022. PMID: 36383742 Clinical Trial.

5

Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis.

Hock RS, Feeney A, Iovieno N, Murrough JW, Mathew SJ, Iosifescu DV, Fava M, Jha MK, Papakostas GI. Hock RS, et al. Among authors: mathew sj. J Clin Psychiatry. 2022 Dec 12;84(1):21r14086. doi: 10.4088/JCP.21r14086. J Clin Psychiatry. 2022. PMID: 36516320

6

Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics.

Carreon RL, Rivas-Grajales AM, Murphy N, Mathew SJ, Jha MK. Carreon RL, et al. Among authors: mathew sj. Adv Neurobiol. 2023;30:287-297. doi: 10.1007/978-3-031-21054-9_12. Adv Neurobiol. 2023. PMID: 36928855

7

Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics.

Vas C, Jain A, Trivedi M, Jha MK, Mathew SJ. Vas C, et al. Among authors: mathew sj. Psychiatr Clin North Am. 2023 Jun;46(2):261-275. doi: 10.1016/j.psc.2023.02.012. Epub 2023 Mar 25. Psychiatr Clin North Am. 2023. PMID: 37149344 Review.

8

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

Anand A, Mathew SJ, Sanacora G, Murrough JW, Goes FS, Altinay M, Aloysi AS, Asghar-Ali AA, Barnett BS, Chang LC, Collins KA, Costi S, Iqbal S, Jha MK, Krishnan K, Malone DA, Nikayin S, Nissen SE, Ostroff RB, Reti IM, Wilkinson ST, Wolski K, Hu B. Anand A, et al. Among authors: mathew sj. N Engl J Med. 2023 Jun 22;388(25):2315-2325. doi: 10.1056/NEJMoa2302399. Epub 2023 May 24. N Engl J Med. 2023. PMID: 37224232 Clinical Trial.

9

Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression-Advantage Ketamine?

Mathew SJ, Jha MK, Anand A. Mathew SJ, et al. JAMA Psychiatry. 2023 Dec 1;80(12):1187-1188. doi: 10.1001/jamapsychiatry.2023.3979. JAMA Psychiatry. 2023. PMID: 37878334

10

Anti-suicidal effects of IV ketamine in a real-world setting.

O'Brien B, Lee J, Kim S, Nandra GS, Pannu P, Tamman A, Amarneh D, Swann AC, Murphy N, Averill L, Jha M, Mathew SJ. O'Brien B, et al. Among authors: mathew sj. Psychiatry Res. 2024 Jan;331:115604. doi: 10.1016/j.psychres.2023.115604. Epub 2023 Nov 14. Psychiatry Res. 2024. PMID: 38064911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page